UPC will be a game changer for businesses across Europe

https://player.vimeo.com/video/155522773

Alia Knight, Head of Generic Litigation at TEVA talks to us about why the introduction of the UPC will be a real game changer for businesses across Europe.

5 May 2019

Outlaw patent RSS feed

EU court limits pharma's scope for patent extensions22 Mar 2019
Supplementary protection certificates (SPCs) are not available for formulations of medicines that contain substances previously authorised for use in the EU, the EU's highest court has ruled.
Brexit a factor in patents court reference to CJEU5 Mar 2019
The UK's impending exit from the EU was a leading factor in a High Court judge's recent decision to seek immediate clarity from the EU's highest court on how to interpret EU intellectual property (IP) laws concerning supplementary protection certificates (SPCs).
Export manufacturing waiver moves closer21 Feb 2019
EU law makers have agreed to update intellectual property (IP) laws to allow European manufacturers of generic and biosimilar medicines to better compete in global markets, but a body representing some of Ireland's biggest pharmaceutical companies has said the proposals could undermine investment in...
'Internet of things' spurs broad interest in standard essential patent licensing4 Feb 2019
ANALYSIS: A push to set new principles around the licensing of standard-essential patents highlights the growing number of businesses whose operations, products and services now rely on standardised technology.